Dementia

Dementia is not a specific disease. It is a descriptive term for a collection of symptoms that can be caused by a number of disorders that affect the brain. People with dementia have significantly impaired intellectual functioning that interferes with normal activities and relationships.

What Causes Dementia?

Dementia occurs due to loss of brain function that occurs with certain diseases. It can affect several brain functions such as memory, thinking, language, planning, behavior and judgement. Dementias are usually progressive and worsen with time. They usually are degenerative and non reversible.

Aromatherapy for Dementia

Coconut Oil and Dementia

Dementia Treatment

Dementia Symptoms

Childhood Dementia Signs and Symptoms

Parkinson's Compared to Dementia with Lewy Bodies (DLB)

Bright Light Therapy and Dementia

Differences Between Alzheimer's and Dementia

Dementia Prevention

Mixed Dementia Symptoms and Diagnosis

Antidepressants and Dementia: Is There a Link?

See more featured articles »

What is Dementia?

Migraines and Dementia

Transcutaneous Electrical Nerve Stimulation for Dementia

What is Mixed Dementia?

Dementia Diagnosis

Mixed Dementia Prevention and Treatment

Childhood Dementia Causes

Does Depression and Anxiety Increase the Risk of Dementia?

Dementia with Lewy Bodies

Latest Dementia News and Research

Frailty linked to greater cognitive impairment risk in men with chronic kidney disease

New research from the University of Colorado Anschutz Department of Medicine is shedding light on how women and men with chronic kidney disease (CKD) may fare differently as they age and their disease progresses.

23 Sep 2026

Transient ischemic attacks linked to increased long-term dementia risk

Having a transient ischemic attack (TIA) is associated with an increased risk of developing dementia, according to a new study published September 23, 2026, in Neurology, the medical journal of the American Academy of Neurology.

23 Sep 2026

PsychAD studies map molecular mechanisms across major brain disorders

Research led by Mount Sinai scientists within the PsychAD Consortium, a large-scale, multidisciplinary initiative launched in 2019 with support from the National Institute on Aging (NIA), is featured in a landmark collection of nine papers published across the Nature family of journals that maps the molecular mechanisms underlying Alzheimer's disease, Parkinson's disease, schizophrenia, and other brain disorders.

23 Sep 2026

Menopause leaves a blood protein signature linked to brain aging and Alzheimer’s risk

Researchers identified a 16-protein blood signature associated with menopause that tracked more strongly with reproductive hormones than chronological age and was largely replicated in an independent UK Biobank cohort. Higher menopause proteomic scores were also associated with less favorable proteomic aging estimates and poorer cognitive outcomes in older women, including incident Alzheimer’s dementia, although the observational evidence does not establish causality.

23 Sep 2026

People with dementia can participate in research without experiencing significant burden

A multidisciplinary study conducted at the University of Eastern Finland has shown that people with dementia and their caregivers can participate in demanding research without experiencing a significant burden.

23 Sep 2026

C-Path awards $1.7 million to advance five drug development projects

Critical Path Institute (C-Path) today announced that its Translational Therapeutics Accelerator has awarded $1,699,500 through five Bridging Research and Innovation in Drug Development Grants (BRIDGe).

22 Sep 2026

Loneliness and social isolation cost people years of healthy life

The numbers paint a grim picture. Roughly half of all U.S. adults are lonely, according to a 2023 report, and nearly as many feel socially isolated.

22 Sep 2026

Low spinal bone density may predict faster brain aging

Researchers at Johns Hopkins University found that lower bone mineral density in the spine was associated with faster cognitive decline and accelerated age-related white matter injury, according to a new study published today in Radiology, a journal of the Radiological Society of North America.

22 Sep 2026

KAIST researchers develop NUDGE technology to steer cell fate

Which genes need to be controlled to guide a stem cell toward a desired cell type, or to modulate an immune cell's inflammatory response? A Korean research team has developed a general-purpose computational framework that identifies the key targets needed to steer a cell toward a desired state with a single temporary intervention, without permanently altering its genes.

22 Sep 2026

Brain Health WA resource aims to reduce dementia risk

With Western Australia projected to record the nation's fastest growth in dementia cases, a new Curtin University-led resource aims to help people protect their brain health and reduce their risk.

22 Sep 2026

Galimedix establishes Scientific Advisory Board for Alzheimer’s disease to guide development of novel oral drug candidate, GAL-101

Galimedix Therapeutics, Inc., a Phase 2 clinical-stage biotechnology company developing novel oral and topical neuroprotective therapies with the potential to revolutionize the treatment of serious brain and eye diseases, today announced the establishment of a dedicated Alzheimer's Disease Scientific Advisory Board (SAB).

From Galimedix Therapeutics, INC. 22 Sep 2026

High cognitive impairment rates among homeless people demand radical policy change

Cognitive impairment is a prevalent but often unaddressed factor in chronic homelessness, and it must be addressed to help reduce homelessness, argues the author of a commentary published in CMAJ

21 Sep 2026

Active form of meprin-β protein increases in people with Alzheimer’s disease

A team from the Altered Molecular Mechanism in Alzheimer's Disease and Dementia laboratory, led by Javier Sáez Valero, a researcher at the Institute for Neurosciences (IN), a joint centre of the Miguel Hernández University of Elche (UMH) and the Spanish National Research Council (CSIC), has identified increased levels of the protein meprin-β in the brain and cerebrospinal fluid of people with Alzheimer's disease.

21 Sep 2026

Older adults with higher polyphenol intake were less likely to have mild cognitive impairment

In a cross-sectional study of 92 older Italian memory-clinic patients, higher habitual intake of total dietary (poly)phenols and several specific subclasses was associated with a lower likelihood of mild cognitive impairment (MCI). Total (poly)phenol intake was not associated with cognitive test performance or circulating inflammatory biomarkers, and the authors cautioned that the small observational study cannot establish causality.

20 Sep 2026

Study identifies brain mechanism behind pregnancy-related food cravings

Why do food cravings become so strong during pregnancy? Researchers at LSU's Pennington Biomedical Research Center, in collaboration with colleagues, have identified a brain mechanism that may help explain how pregnancy changes the motivation to seek certain highly palatable foods.

18 Sep 2026

Otolaryngologists gather to present latest advances in ear, nose, and throat care

The latest treatments and research advances in ear, nose, and throat care will take center stage in Los Angeles October 17-20, when more than 5,000 of the world's leading otolaryngologists gather for the 2026 Annual Meeting & OTO EXPO of the American Academy of Otolaryngology–Head and Neck Surgery Foundation.

18 Sep 2026

Social media posts misrepresent Alzheimer's blood test recommendations

Researchers have raised concerns about the promotion of Alzheimer's disease blood tests on social media, particularly posts making claims that do not align with current clinical recommendations.

17 Sep 2026

Study highlights drop in harmful medication use among adults with cognitive disorders

Adults 65 and older with cognitive disorders such as dementia, are more likely to suffer negative effects from drugs that treat central nervous system conditions including anxiety, sleep problems and psychosis.

17 Sep 2026

Young onset dementia creates years of uncertainty for families

Families caring for a loved one with young onset dementia are facing years of uncertainty, financial strain and emotional exhaustion - with many struggling to access timely diagnosis and appropriate support, according to a new Curtin University study.

16 Sep 2026